Clinical Trial Results

Viewing Page 1 of 1 | Showing Results 1 - 3 of 3

Phase 3 Randomized Double-Blind Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Remdesivir (GS-5734™) Treatment of COVID-19 in an Outpatient Setting

The primary objectives of this study are to evaluate the efficacy of remdesivir (RDV) in reducing the rate of hospitalization or death in...

Tobias Pusch, M.D.
  • Providence Portland Medical Center

NCI COVID-19 in Cancer Patients Study (NCCAPS): A Longitudinal Natural History Study.

This study collects blood samples, medical information, and medical images from patients who are being treated for cancer and have a positive test...

Gary Goodman, M.D.

The Pacific Cancer Research Consortium clinical trials are offered at multiple locations throughout Oregon, Washington, Alaska, California, and Idaho. To find a location near you, please contact the Patient Engagement Center at 844-552-2734.

A Master Protocol Assessing the Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for the Treatment of Hospitalized Patients With COVID-19

The primary objectives are:Phase 1• To evaluate the safety and tolerability of REGN10933+REGN10987 compared to placebo• To evaluate the virologic...

Jason Wells, M.D.
  • Providence Portland Medical Center
  • Providence St. Vincent Medical Center
Viewing Page 1 of 1 | Showing Results 1 - 3 of 3